WO2006131340A3 - Inhibiteurs de la peptide deformylase (pdf) 3 - Google Patents
Inhibiteurs de la peptide deformylase (pdf) 3 Download PDFInfo
- Publication number
- WO2006131340A3 WO2006131340A3 PCT/EP2006/005429 EP2006005429W WO2006131340A3 WO 2006131340 A3 WO2006131340 A3 WO 2006131340A3 EP 2006005429 W EP2006005429 W EP 2006005429W WO 2006131340 A3 WO2006131340 A3 WO 2006131340A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- inhibitors
- pyrrolones
- act
- peptide deformylase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/38—2-Pyrrolones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne des composés de formule (I). Ces composés sont de nouveaux inhibiteurs de la peptide déformylase (PDF) et présentent un grand intérêt, en particulier, comme antibiotiques, agents anticancéreux, antiparasitaires et herbicides.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005026231A DE102005026231A1 (de) | 2005-06-07 | 2005-06-07 | Peptid-Deformylase (PDF) Inhibitoren 3 |
DE102005026231.7 | 2005-06-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006131340A2 WO2006131340A2 (fr) | 2006-12-14 |
WO2006131340A3 true WO2006131340A3 (fr) | 2007-04-19 |
Family
ID=37056748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/005429 WO2006131340A2 (fr) | 2005-06-07 | 2006-06-07 | Inhibiteurs de la peptide deformylase (pdf) 3 |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE102005026231A1 (fr) |
WO (1) | WO2006131340A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008127274A2 (fr) * | 2006-09-22 | 2008-10-23 | Ptc Therapeutics, Inc. | Inhibiteurs hétérocycliques d'hydrolase d'arnt peptidyle bactérienne et utilisations de ceux-ci |
US11034669B2 (en) | 2018-11-30 | 2021-06-15 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002102790A1 (fr) * | 2001-06-15 | 2002-12-27 | Vicuron Pharmaceuticals Inc. | Composes de n-formyle hydroxylamine en tant qu'inhibiteurs de peptidyle deformylase (pdf) |
WO2004099124A2 (fr) * | 2003-05-08 | 2004-11-18 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Nouveaux bioisosteres d'actinonine |
WO2005027882A1 (fr) * | 2003-09-22 | 2005-03-31 | Bionetworks Gmbh | Prevention et traitement de la perte osseuse induite par inflammation et/ou immuno-mediee |
-
2005
- 2005-06-07 DE DE102005026231A patent/DE102005026231A1/de not_active Ceased
-
2006
- 2006-06-07 WO PCT/EP2006/005429 patent/WO2006131340A2/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002102790A1 (fr) * | 2001-06-15 | 2002-12-27 | Vicuron Pharmaceuticals Inc. | Composes de n-formyle hydroxylamine en tant qu'inhibiteurs de peptidyle deformylase (pdf) |
WO2004099124A2 (fr) * | 2003-05-08 | 2004-11-18 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Nouveaux bioisosteres d'actinonine |
WO2005027882A1 (fr) * | 2003-09-22 | 2005-03-31 | Bionetworks Gmbh | Prevention et traitement de la perte osseuse induite par inflammation et/ou immuno-mediee |
Non-Patent Citations (3)
Title |
---|
DATABASE REGISTRY [online] 18 August 2004 (2004-08-18), XP002402347, retrieved from STN * |
DATABASE REGISTRY [online] 18 October 2000 (2000-10-18), XP002402346, retrieved from STN * |
DATABASE REGISTRY [online] 20 November 2001 (2001-11-20), XP002402345, retrieved from STN * |
Also Published As
Publication number | Publication date |
---|---|
DE102005026231A1 (de) | 2006-12-14 |
WO2006131340A2 (fr) | 2006-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007077186A8 (fr) | Inhibiteurs de pdf | |
WO2006072615A3 (fr) | Triazolophtalazines | |
WO2006072612A3 (fr) | Triazolophthalazines | |
WO2007067506A3 (fr) | Inhibiteurs d'erbb kinase de 2-pyrimidinyl-pyrazolopyridine | |
WO2007016674A3 (fr) | Aryl pyridines et procédés pour leur utilisation | |
WO2005066151A3 (fr) | Inhibiteurs d'histone desacetylase | |
WO2007106670A3 (fr) | Composes de n-formyle hydroxylamine | |
WO2007079164A3 (fr) | Inhibiteurs de protéines kinases | |
WO2007133290A8 (fr) | Anticorps anti-ox40l et méthodes correspondantes | |
TW200610531A (en) | Phthalazine derivatives as PARP inhibitors | |
WO2007148185A3 (fr) | 3-amino-pyrrolidino-4-lactames substitués | |
WO2007027238A3 (fr) | Inhibiteurs de kinase jak et utilisations de ceux-ci | |
WO2006024640A3 (fr) | Triazolophtalazines | |
SG154432A1 (en) | Quinazolinedione derivatives as parp inhibitors | |
WO2007064872A3 (fr) | Composes de l'uree utilises dans le traitement du cancer | |
WO2004074244A3 (fr) | Composes de pyrimidine | |
WO2007065595A3 (fr) | Derives de la xanthine, procedes de preparation et utilisations de ceux-ci | |
WO2007120333A3 (fr) | Inhibiteurs de kinase tétracycliques | |
WO2007062308A3 (fr) | Inhibiteurs de cetp heterocycliques | |
WO2007056625A3 (fr) | Inhibiteurs de thienopyridine b-raf kinase | |
EA200800357A1 (ru) | Новые фармацевтические соединения | |
WO2006097617A3 (fr) | Nouveaux derives dihydropyrimidines et leur utilisation comme agents anti-cancereux | |
WO2006133006A3 (fr) | 1-methyl-1h-pyrazole-4-carboxamides utiles comme agents chimiotherapeutiques anticancereux | |
WO2009105969A8 (fr) | Analogues d'épothilone, leurs compositions pharmaceutiques, leur utilisation et leurs préparations | |
WO2007022102A3 (fr) | Inhibiteurs pentatycliques des kinases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06743122 Country of ref document: EP Kind code of ref document: A2 |